Free Content Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function

Authors: Kamerling I.M.C.1; van Haarst A.D.1; Burggraaf J.1; Schoemaker R.C.1; de Kam M.L.1; Heinzerling H.2; Cohen A.F.1; Masclee A.A.M.3

Source: British Journal of Clinical Pharmacology, Volume 57, Number 4, April 2004 , pp. 393-401(9)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aim

To assess the effects of the motilin receptor antagonist RWJ-68023 on basal and motilin-stimulated proximal gastric volume. Methods

Eighteen healthy male volunteers received RWJ-68023 in two different doses or placebo for 135 min. After 45 min, subjects received a motilin infusion for 90 min. Proximal gastric volume was measured with a barostat at constant pressure and during isobaric distensions. Abdominal symptoms were scored using visual analogue scales. Motilin and RWJ-68023 concentrations were assessed by radioimmunoassay and liquid chromatography-mass spectrometry, respectively. Results

Both dosages of RWJ-68023 were safe and well tolerated. The most common adverse events were of gastrointestinal origin. RWJ-68023 did not affect basal proximal gastric volume, but the high-dose RWJ-68023 reduced the contractile effect of motilin on the stomach. This antagonizing effect of RWJ-68023 was only significant (P = 0.014) during the distension procedure. Conclusions

The RWJ-68023 doses used in this study were selected to accomplish plasma concentrations that would block the motilin effect entirely. However, the antagonizing effect of RWJ-68023 was partial and only present when the tonic condition of the stomach was modulated by motilin.

Keywords: antagonist; human and barostat; motilin; stomach

Document Type: Research article

DOI: 10.1046/j.1365-2125.2003.02034.x

Affiliations: 1: Centre for Human Drug Research, Leiden, the Netherlands, 2: Johnson & Johnson Pharmaceutical Research and Development, Janssen-Cilag, High Wycombe, UK, and 3: Leiden University Medical Centre, Department of Gastroenterology, Leiden, the Netherlands

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A